141TiPASTRIS: A multicenter, real world treatment study of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC)
Cheema, P.K., Chen, Y-M., de Marinis, F., Freitas, H.C., Kim, S-W., Milner, A., Provencio, M., Rigas, J., Wu, Y-L.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx091.061
Date:
April, 2017
File:
PDF, 50 KB
english, 2017